PFN1 (Profilin 1) is a small actin-binding protein that regulates actin polymerization and cytoskeletal dynamics. PFN1 mutations are causally linked to amyotrophic lateral sclerosis (ALS), making it a critical protein in understanding motor neuron degeneration.
| PFN1 Protein |
|---|
| Gene | [PFN1](/genes/pfn1) |
| UniProt ID | [P07737](https://www.uniprot.org/uniprotkb/P07737) |
| PDB Structures | 1PFL, 2BT0, 4X1L |
| Molecular Weight | ~15 kDa |
| Subcellular Localization | Cytosol, membrane |
| Protein Family | Profilin family |
PFN1 is a 15 kDa actin-binding protein with a distinctive fold:
- Actin-binding site: Binds globular (G)-actin with high affinity
- Poly-L-proline binding: Interacts with proline-rich proteins including formins
- Phosphatidylinositol binding: Associates with membrane phospholipids
- ALS mutations: C71G, M114T, G118V disrupt actin binding and function
The protein forms a compact beta-sheet structure flanked by alpha-helices.
In neurons, PFN1 performs essential cytoskeletal functions:
- Actin Dynamics: Promotes actin filament elongation by exchanging ADP for ATP on actin
- Cytoskeletal Organization: Maintains neuronal morphology and axonal transport
- Synaptic Function: Regulates presynaptic actin and neurotransmitter release
- Axonal Growth: Essential for axonal guidance and regeneration
- Stress Granules: Associates with stress granule dynamics under cellular stress
- RNA Processing: Interacts with RNA-binding proteins in neuronal granules
PFN1 is ubiquitously expressed, with high levels in motor neurons, hippocampal neurons, and cortical pyramidal cells.
- Causal gene: PFN1 mutations are a rare cause of familial ALS
- Actin dysfunction: Mutant PFN1 impairs actin polymerization in motor neurons
- Stress granule accumulation: Aberrant stress granule dynamics in PFN1-ALS
- Axonal transport defects: Disrupted cytoskeletal trafficking in motor neurons
- TDP-43 pathology: PFN1 mutations exacerbate TDP-43 aggregation
- Frontotemporal Dementia (FTD): PFN1 interacts with FTD-related proteins
- Huntington's Disease: Altered profilin levels affect cytoskeletal function
- Alzheimer's Disease: Profilin involvement in synaptic dysfunction
Therapeutic strategies for PFN1-related neurodegeneration:
| Approach |
Mechanism |
Development Stage |
| Gene therapy |
Wild-type PFN1 delivery |
Research |
| Actin stabilizers |
Restore cytoskeletal function |
Drug screening |
| Stress granule modulators |
Normalize granule dynamics |
Preclinical |
| Small molecules |
Correct mutant PFN1 function |
Lead optimization |
- Wu et al., PFN1 mutations cause ALS (2012)
- Albet et al., PFN1 and actin dynamics in ALS (2014)
- Fil et al., PFN1 stress granules (2016)
- Deng et al., PFN1 ALS mechanisms (2021)
- Smith et al., Targeting profilin in neurodegeneration (2023)